$ Value
$2.0M
Shares
130,000
Price
$15
Filed
Dec 10
Insider
Name
Reich Kristian
Title
Chief Scientific Officer
CIK
0001920553
Roles
Transaction Details
Transaction Date
2025-12-08
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
72,908
Footnotes
Sales made pursuant to Rule 144 under the Securities Act of 1933, as amended, to cover tax liabilities of the Reporting Person and other expenses incurred related to the sales. | The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.036949 to $15.101507. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. | Represents the ordinary shares of the Issuer owned by JeruCON Beratungsgesellschaft mbH. Dr. Reich directly (whether through ownership or position) or indirectly through one or more intermediaries, may be deemed for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, to be the indirect beneficial owner of the ordinary shares owned by JeruCON Beratungsgesellschaft mbH.
Filing Info
Reich Kristian's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-07 | MLTX | A | $0 |
| 2025-12-19 | MLTX | C | — |
| 2025-12-19 | MLTX | D | — |
| 2025-12-19 | MLTX | C | — |
| 2025-12-09 | MLTX | ▼ | $1.1M |
| 2025-12-08 | MLTX | ▼ | $2.0M |
| 2025-09-02 | MLTX | C | — |
| 2025-09-02 | MLTX | D | — |
| 2025-01-20 | MLTX | C | — |
Other Insiders at MLTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BVF PARTNERS L P/IL | — | $63.0M | 2026-03-31 |
|
Santos da Silva Jorge
Chief Executive Officer
|
— | $2.8M | 2026-04-13 |
|
Bodenstedt Matthias
Chief Financial Officer
|
— | $1.7M | 2026-04-14 |